December 30, 2021 10:52 AM EST
Manufacturing

Fol­low­ing in­flux of cash, Pi­ra­mal in­vests in an­oth­er In­di­an CD­MO; US inks deal with man­u­fac­tur­er of rapid Covid-19 tests

Josh Sullivan

In­di­an CD­MO Ya­pan Bio has land­ed an in­vest­ment from Pi­ra­mal Phar­ma, the com­pa­ny an­nounced, to help en­hance its man­u­fac­tur­ing arm. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Ex­clu­sive: First-of-its-kind in­fant DNA ed­it leads to ap­par­ent cure in dis­ease that set back field 25 years ago

Up­dat­ed: Gala­pa­gos to split in­to two com­pa­nies, slash head­count as it eyes turn­around

MaaT Phar­ma touts ‘un­prece­dent­ed’ Phase 3 ef­fi­ca­cy of graft-ver­sus-host dis­ease treat­ment

Astel­las stops de­vel­op­ing au­tol­o­gous cell ther­a­py us­ing tech from Xyphos buy­out

Gene edit­ing start­up Scribe Ther­a­peu­tics lets go of staff as it preps for the clin­ic

Pfiz­er, GSK add risk of Guil­lain-Bar­ré to RSV vac­cine la­bels at FDA's re­quest

A service from the Financial Times